ArticleFuture oncology (London, England)2025

Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC.

Christophe Le Tourneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.